MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Insulet Corp

Затворен

СекторЗдравеопазване

318.75 1.01

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

317.57

Максимум

321.61

Ключови измерители

By Trading Economics

Приходи

-13M

23M

Продажби

80M

649M

P/E

Средно за сектора

96.196

36.442

Марж на печалбата

3.466

Служители

3,900

EBITDA

-8.7M

70M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+15.61% upside

Дивиденти

By Dow Jones

Следващи печалби

6.11.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

1.9B

22B

Предишно отваряне

317.74

Предишно затваряне

318.75

Настроения в новините

By Acuity

16%

84%

24 / 371 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Weak Bearish Evidence

Insulet Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

17.10.2025 г., 18:13 ч. UTC

Значими двигатели на пазара

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17.10.2025 г., 17:05 ч. UTC

Значими двигатели на пазара

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

18.10.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Deal Expected to Value Unit at Roughly $4B, Sources Say -- WSJ

18.10.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Deal Could Be Announced as Soon as Next Week, Sources Say -- WSJ

18.10.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L'Oréal -- WSJ

18.10.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Gucci Parent Kering in Talks to Sell Beauty Business to L'Oréal, Sources Say -- WSJ

18.10.2025 г., 08:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

18.10.2025 г., 07:00 ч. UTC

Печалби

A Growing Nimby Movement Could Upend the Data Center Boom -- Barrons.com

17.10.2025 г., 23:25 ч. UTC

Придобивния, сливания и поглъщания

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17.10.2025 г., 22:15 ч. UTC

Пазарно говорене

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17.10.2025 г., 21:15 ч. UTC

Пазарно говорене

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17.10.2025 г., 21:07 ч. UTC

Пазарно говорене

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17.10.2025 г., 21:07 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

17.10.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

17.10.2025 г., 20:34 ч. UTC

Пазарно говорене

Deere Is Reaching the End of Its Downcycle -- Market Talk

17.10.2025 г., 20:27 ч. UTC

Пазарно говорене

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17.10.2025 г., 19:46 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17.10.2025 г., 19:45 ч. UTC

Пазарно говорене

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17.10.2025 г., 18:45 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17.10.2025 г., 17:51 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.10.2025 г., 17:51 ч. UTC

Пазарно говорене

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17.10.2025 г., 17:44 ч. UTC

Пазарно говорене

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17.10.2025 г., 17:35 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17.10.2025 г., 16:20 ч. UTC

Пазарно говорене
Печалби

Tech, Media & Telecom Roundup: Market Talk

17.10.2025 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

17.10.2025 г., 16:14 ч. UTC

Пазарно говорене

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17.10.2025 г., 16:04 ч. UTC

Пазарно говорене

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17.10.2025 г., 15:58 ч. UTC

Пазарно говорене

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17.10.2025 г., 15:56 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17.10.2025 г., 15:43 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Insulet Corp Прогноза

Ценова цел

By TipRanks

15.61% нагоре

12-месечна прогноза

Среден 368.31 USD  15.61%

Висок 415 USD

Нисък 300 USD

Според 17 анализатори от Wall Street, предложили 12-месечна ценова цел за Insulet Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

17 ratings

16

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

252.29 / 259.38Подкрепа & съпротива

Краткосрочен план

Weak Bearish Evidence

Средносрочен план

Strong Bearish Evidence

Дългосрочен план

Bullish Evidence

Настроение

By Acuity

24 / 371 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat